Tango Therapeutics Inc (TNGX) — Cash Flow Reinvestment Rate

Latest as of September 2020: 0.63x

Tango Therapeutics Inc (TNGX) has a Cash Flow Reinvestment Rate of 0.63x as of September 2020, reinvesting $69.75 Million (capex $132.00K plus investments $-69.62 Million) from operating cash flow of $111.26 Million. Explore reinvestment intensity of Tango Therapeutics Inc to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.63x
(Capex + Investments) / Operating CF

Total Reinvested

$69.75 Million
Capex + Investments

Operating Cash Flow

$111.26 Million
USD

Capital Expenditures

$132.00K
USD

Tango Therapeutics Inc Cash Flow Reinvestment Rate (2020–2020)

Historical reinvestment intensity for Tango Therapeutics Inc across 1 annual periods. Also explore how large is Tango Therapeutics Inc's balance sheet for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Tango Therapeutics Inc (2020–2020)

Year-by-year capital reinvestment analysis for Tango Therapeutics Inc. For live market cap and broader valuation context, see Tango Therapeutics Inc stock valuation.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2020 2.08x $145.43 Million $70.07 Million $1.11 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow